MAO-B inhibitors useful for treating obesity

Organic compounds -- part of the class 532-570 series – Organic compounds – Amino nitrogen containing

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S654000

Reexamination Certificate

active

07956220

ABSTRACT:
The invention provides novel compounds of formulae I and II:that are monoamine oxidase-B inhibitors, which can be useful in treating obesity, diabetes, and/or cardiometabolic disorders (e.g., hypertension, dyslipidemias, high blood pressure, and insulin resistance).

REFERENCES:
patent: 3397236 (1968-08-01), Watson, Jr.
patent: 3485874 (1969-12-01), Zoltan et al.
patent: 3775479 (1973-11-01), Bruderer et al.
patent: 4564706 (1986-01-01), Ecsery et al.
patent: 5159081 (1992-10-01), Cantrell et al.
patent: 5238962 (1993-08-01), Da Prada et al.
patent: 5250542 (1993-10-01), Cantrell et al.
patent: 5270328 (1993-12-01), Cantrell et al.
patent: 5434171 (1995-07-01), Frank et al.
patent: 5990151 (1999-11-01), Nakazato et al.
patent: 6251938 (2001-06-01), Chorev et al.
patent: 6375979 (2002-04-01), DiSanto
patent: 6635667 (2003-10-01), Thomas
patent: 2004/0010038 (2004-01-01), Blaugrund et al.
patent: 0 076 557 (1983-04-01), None
patent: 96/26720 (1996-09-01), None
patent: 98/22110 (1998-05-01), None
patent: 99/06369 (1999-02-01), None
patent: 99/36422 (1999-07-01), None
patent: 99/06369 (1999-11-01), None
patent: 01/90081 (2001-11-01), None
patent: 03/072055 (2003-09-01), None
Sterling et al., J. Med. Chem., 2002, v. 45, p. 5260-5279.
Topliss, J. Med. Chem., 1977, v. 20, p. 463-469.
Yu et al. (The International Journal of Biochemistry & Cell Biology 31 (1999) 1391-1397).
Patani et al. (Chem. Rev., 1996, vol. 96, No. 8, p. 3147-3176).
Kubinyi, 3D QSAR in Drug Design: Ligand-Protein Interactions and Molecular Similarity, vol. 2-3, Springer, 1998, 800 pages. table of contents and pp. 243-244 provided.
Visentin, Virgile, et al., Alteration of Amine Oxidase Activity in the Adipose Tissue of Obese Subjects, Obesity Research vol. 12 No. 3 Mar. 2004, pp. 547-555.
Visentin, Virgile, et al., Inhibition of Rat Fat Cell Lipolysis by Monoamine Oxidase and Semicarbazide-Sensitive Amine Oxidase Substrates, European Journal of Pharmacology 466 (2003) 235-243.
John V Duncia, Michael E. Pierce, and Joseph B Santella III, Three Synthetic Routes to a Sterically Hindered Tetrazole. A New One-Step Mild Conversion of an Amide into a Tetrazole; J. Org. Chem. 1991, 56, 2395-2400.
Wei Zhang, Shunichi Oya, Mei-Ping Kung, Catherine Hou, Donna L. Maier, and Hank F. Kung, F-18 Polyethyleneglycol Stilbenes as PET Imaging Agents Targeting AB Aggregates in the Brain; Nuclear Medicine and Biology 2005, 32, 799-809.
Joseph Knoll, Zoltan Ecsery, Kalman Magyar, and Eva Satory, Novel (-)Deprenyl-Derived Selective Inhibitors of B-Type Monoamine Oxidase. The Relation of Structure to Their Action; Biochemical Pharmacology 1978, 27, 1739-47.
Lin, Xiaodong et al., Utilization of Fukuyama's sulfonamide protecting group for the synthesis of N-substituted alpha-amino acids and derivatives, Tetrahedron Letters 2000, 41(18), 3309-13.
Tarjanyi, Zsofia et al., Chromatographic investigation and computer simulation of (-)deprenyl metabolism, New Approaches Chromatogr. '93 (Pap Budapest Chromatogr. Conf.], Meeting Date 1990, 243-260.
Magyar, K. et al., Structure-activity relationship of selective inhibitors of MAO-B, Adv. Pharmacol. Res. Pract., Proc. Congr. Hung. Pharmacolo. Soc., 3rd, 1979, 4, 11-21.
Extended European Search Report for EP 06774472.2-21401/1906952 (PCT/US2006/026004).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

MAO-B inhibitors useful for treating obesity does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with MAO-B inhibitors useful for treating obesity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and MAO-B inhibitors useful for treating obesity will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2688691

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.